Meyler's Side Effects of Endocrine and Metabolic Drugs (Meyler's Side Effects of Drugs)

Elsevier now offers a series of derivative works based on the acclaimed Meylers Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing physician or health care clinician. Endocrine and metabolic diseases are common, includes diseases such as diabetes, thyroid disease, and obesity. Endocrinologists, including diabetes professionals, internal medicine and primary care practitioners, obstetricians and gynecologists, and others will find this book useful when treating endocrine or metabolic diseases. The material is drawn from the 15 th edition of the internationally renowned encyclopedia, Meyler’s Side Effects of Drugs, and the latest volumes in the companion series, Side Effects of Drugs Annuals. Drug names have usually been designated by their recommended or proposed International Non-proprietary Names (rINN or pINN); when those are not available, clinical names have been used. In some cases, brand names have been used. This volume is critical for any health professional involved in the administration of endocrine and metabolics mediations. Surpasses the Physician’s Desk Reference © by including clinical case studies and independent expert analysis Complete index of drug names Most complete cross referencing of drug-drug interactions available Extensive references to primary and secondary literature Also includes information on adverse effects in pregnancy The book is divided into eight sections: Corticosteroids and related drugs Prostaglandins Sex hormones and related drugs Iodine and drugs that affect thyroid function Insulin and other hypoglycemic drugs Other hormones and related drugs Lipid-regulated drugs Endocrine and metabolic adverse effects of non-hormonal and non-metabolic drugs Meyler's Side Effects of Endocrine and Metabolic Drugs......Page 4 Copyright Page......Page 5 Contents......Page 6 Preface......Page 8 Section 1 Corticosteroids and related drugs......Page 12 General Information......Page 14 Organs and Systems......Page 17 Long-Term Effects......Page 50 Second-Generation Effects......Page 52 Susceptibility Factors......Page 56 Drug Administration......Page 57 Drug—Drug Interactions......Page 64 Diagnosis of adverse drug reactions......Page 65 References......Page 66 General Information......Page 81 Organs and Systems......Page 84 Drug–Drug Interactions......Page 98 References......Page 99 References......Page 104 References......Page 105 Organs and Systems......Page 106 Second-Generation Effects......Page 108 References......Page 109 Section 2 Prostaglandins......Page 112 General Information......Page 114 Susceptibility Factors......Page 118 Drug Administration......Page 119 References......Page 120 Organs and Systems......Page 123 References......Page 126 Drug Administration......Page 127 General Information......Page 128 Organs and Systems......Page 129 References......Page 130 General Information......Page 131 Organs and Systems......Page 132 Organs and Systems......Page 133 References......Page 137 General Information......Page 138 Second-Generation Effects......Page 140 References......Page 142 Organs and Systems......Page 144 Reference......Page 145 Section 3 Sex hormones and related drugs......Page 146 General Information......Page 148 Organs and Systems......Page 150 Long-Term Effects......Page 153 Susceptibility Factors......Page 155 Drug Administration......Page 156 References......Page 157 General Information......Page 160 Organs and Systems......Page 163 Drug Administration......Page 166 References......Page 167 Organs and Systems......Page 170 Long-Term Effects......Page 171 References......Page 172 General Information......Page 173 Long-Term Effects......Page 174 References......Page 175 Organs and Systems......Page 176 Organs and Systems......Page 177 Second-Generation Effects......Page 178 References......Page 182 General Information......Page 183 Organs and Systems......Page 185 Long-Term Effects......Page 189 Susceptibility Factors......Page 201 Drug Administration......Page 202 References......Page 204 General Information......Page 211 Organs and Systems......Page 212 Long-Term Effects......Page 214 Drug Administration......Page 216 References......Page 217 General Information......Page 219 References......Page 221 References......Page 222 References......Page 223 General Information......Page 224 Organs and Systems......Page 226 Long-Term Effects......Page 246 Second-Generation Effects......Page 247 Susceptibility Factors......Page 248 Drug Administration......Page 249 Drug—Drug Interactions......Page 250 References......Page 253 General Information......Page 263 General Information......Page 264 Organs and Systems......Page 267 Drug Administration......Page 268 References......Page 269 General Information......Page 270 Organs and Systems......Page 272 Susceptibility Factors......Page 277 Drug Administration......Page 278 Drug—Drug Interactions......Page 280 References......Page 281 General Information......Page 284 General Information......Page 285 Organs and Systems......Page 287 Susceptibility Factors......Page 289 References......Page 290 Organs and Systems......Page 292 Drug Administration......Page 294 References......Page 295 General Information......Page 296 Organs and Systems......Page 297 References......Page 298 General Information......Page 299 Organs and Systems......Page 301 Second-Generation Effects......Page 303 Drug Administration......Page 304 References......Page 306 General Information......Page 308 Organs and Systems......Page 309 References......Page 310 General Information......Page 312 Organs and Systems......Page 314 Long-Term Effects......Page 318 Drug—Procedure Interactions......Page 320 References......Page 321 References......Page 325 Section 4 Iodine and drugs that affect thyroid function......Page 326 General Information......Page 328 Organs and Systems......Page 330 Drug Administration......Page 332 References......Page 333 Organs and Systems......Page 335 Long-Term Effects......Page 336 Second-Generation Effects......Page 337 References......Page 338 General Information......Page 339 Organs and Systems......Page 340 Susceptibility Factors......Page 342 References......Page 343 Organs and Systems......Page 345 General Information......Page 346 Organs and Systems......Page 347 Second-Generation Effects......Page 351 References......Page 353 General Information......Page 357 Organs and Systems......Page 358 Susceptibility Factors......Page 361 Drug—Drug Interactions......Page 362 Monitoring Therapy......Page 363 References......Page 364 References......Page 366 Section 5 Insulins and other hypoglycemic drugs......Page 368 General Information......Page 370 Organs and Systems......Page 371 Drug—Drug Interactions......Page 374 References......Page 375 General Information......Page 377 General Information......Page 378 Organs and Systems......Page 381 Second-Generation Effects......Page 386 Drug Administration......Page 387 Drug—Drug Interactions......Page 388 References......Page 389 General Information......Page 393 General information......Page 394 General Information......Page 395 Susceptibility Factors......Page 396 Organs and Systems......Page 397 References......Page 398 Organs and Systems......Page 399 Long-Term Effects......Page 400 References......Page 401 General Information......Page 402 Organs and Systems......Page 404 Second-Generation Effects......Page 414 Drug Administration......Page 415 Drug—Drug Interactions......Page 422 Interference with Diagnostic Tests......Page 423 References......Page 424 General Information......Page 433 References......Page 434 General Information......Page 435 General Information......Page 436 Organs and Systems......Page 437 References......Page 438 General Information......Page 439 Organs and Systems......Page 440 References......Page 442 Organs and Systems......Page 444 General Information......Page 445 Organs and Systems......Page 448 Drug—Drug Interactions......Page 449 References......Page 450 General Information......Page 452 Organs and Systems......Page 454 Second-Generation Effects......Page 459 Drug Administration......Page 460 Drug—Drug Interactions......Page 462 References......Page 464 General Information......Page 469 Organs and Systems......Page 472 Drug—Drug Interactions......Page 479 References......Page 480 Section 6 Other hormones and related drugs......Page 486 Organs and Systems......Page 488 References......Page 489 General Information......Page 490 Organs and Systems......Page 491 Drug—Drug Interactions......Page 494 References......Page 495 General Information......Page 497 Organs and Systems......Page 498 Long-Term Effects......Page 501 References......Page 502 References......Page 505 Organs and Systems......Page 506 Drug—Drug Interactions......Page 508 General Information......Page 509 Second-Generation Effects......Page 510 Organs and Systems......Page 511 References......Page 512 General Information......Page 513 Organs and Systems......Page 514 Second-Generation Effects......Page 516 References......Page 517 Organs and Systems......Page 519 Long-Term Effects......Page 524 Drug Administration......Page 525 References......Page 526 Organs and Systems......Page 530 General Information......Page 531 Organs and Systems......Page 532 Drug Administration......Page 533 References......Page 534 References......Page 535 Section 7 Lipid – regulating drugs......Page 538 Organs and Systems......Page 540 Drug Administration......Page 541 References......Page 542 General Information......Page 543 References......Page 544 References......Page 545 Organs and Systems......Page 546 Drug—Drug Interactions......Page 548 References......Page 550 Organs and Systems......Page 552 References......Page 553 Organs and Systems......Page 554 General Information......Page 555 Organs and Systems......Page 556 Drug—Drug Interactions......Page 560 References......Page 563 Organs and Systems......Page 566 Drug—Drug Interactions......Page 567 General Information......Page 568 Drug—Drug Interactions......Page 569 References......Page 570 General Information......Page 571 Organs and Systems......Page 572 Drug-Drug Interactions......Page 574 References......Page 575 Drug—Drug Interactions......Page 576 General Information......Page 577 Organs and Systems......Page 578 Drug—Drug Interactions......Page 579 References......Page 580 Section 8 Endocrine and metabolic adverse effects of non-hormonal and non-metabolic drugs......Page 582 Aldesleukin......Page 584 Amiodarone......Page 585 Amisulpride......Page 589 Antiepileptic drugs......Page 590 Antiretroviral drugs......Page 593 Aripiprazole......Page 595 Benazepril......Page 596 Beta-adrenoceptor antagonists......Page 597 Beta-lactam antibiotics......Page 598 Calcium channel blockers......Page 599 Carbonic anhydrase inhibitors......Page 600 Cardiac glycosides......Page 601 Chloroquine and hydroxychloroquine......Page 602 Ciclosporin......Page 603 Clomipramine......Page 604 Clozapine......Page 605 Cocaine......Page 606 Cyclophosphamide......Page 607 Diazoxide......Page 608 Diuretics......Page 609 Enflurane......Page 611 Fentanyl......Page 612 Flutamide......Page 613 Gatifloxacin......Page 614 Granulocyte—macrophage colony-stimulating factor (GM-CSF)......Page 615 Haloperidol......Page 616 Indinavir......Page 617 Interferon alfa......Page 618 Interferon beta......Page 622 Iodinated contrast media......Page 623 Iron salts......Page 624 Levodopa and dopa decarboxylase inhibitors......Page 625 Lithium......Page 626 Local anesthetics......Page 631 Methyldopa......Page 632 Mizoribine......Page 633 Nelfinavir......Page 634 Neuroleptic drugs......Page 635 Nucleoside analogue reverse transcriptase inhibitors (NRTIs)......Page 641 Olanzapine......Page 642 Opioid analgesics......Page 645 Parenteral nutrition......Page 646 Penicillins......Page 648 Platinum-containing cytostatic drugs......Page 649 Propofol......Page 650 Protease inhibitors......Page 652 Quetiapine......Page 653 Rifamycins......Page 654 Risperidone......Page 655 Salbutamol......Page 657 Sirolimus......Page 658 Sunitinib......Page 659 Tacrolimus......Page 660 Tetracyclines......Page 661 Thiopental sodium......Page 662 Tricyclic antidepressants......Page 663 Valproic acid......Page 664 Vitamin A: Retinoids......Page 667 References......Page 668 Index of drug names......Page 704 "Endocrine and metabolic diseases are common, including diseases such as diabetes, thyroid disease, and obesity. Endocrinologists, including diabetes professionals, internal medicine and primary-care practitioners, obstetricians and gynecologists, and other physicians will find this volume useful when treating endocrine or metabolic diseases." "This book summarizes the adverse effects of a large range of endocrine and metabolic drugs. The material is drawn from the 15th edition of the internationally renowned encyclopedia, Meyler's Side Effects of Drugs: The Encyclopedia of Adverse Drug Reactions and Interactions, and the latest volumes in the companion series, Side Effects of Drugs Annuals."--Résumé de l'éditeur "Endocrine and metabolic diseases are common, including diseases such as diabetes, thyroid disease, and obesity. Endocrinologists, including diabetes professionals, internal medicine and primary-care practitioners, obstetricians and gynecologists, and other physicians will find this volume useful when treating endocrine or metabolic diseases." "This book summarizes the adverse effects of a large range of endocrine and metabolic drugs. The material is drawn from the 15th edition of the internationally renowned encyclopedia, Meyler's Side Effects of Drugs: The Encyclopedia of Adverse Drug Reactions and Interactions, and the latest volumes in the companion series, Side Effects of Drugs Annuals."--BOOK JACKET